CASP3 and Alzheimer disease: All these findings from the morphometric analysis revealed increased mesangial matrix and massive fibrosis along with increased expression of Casp-3 and iNOs in the MTX group with improvement of fibrosis and decreased expression of Casp-3 and iNOs in PRP- and AD-MSC-treated groups.